Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Theriva Biologics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q1 2024
- Shares held
- 1.39M
- +594.4K (+75.1%) vs. Q1 2024
- Total value
- $327.6K
- −$38.8K (−10.6%) vs. Q1 2024
- New holders
- 2
- 5 more added
- Sold out
- 4
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $495.5K |
| Q1 2026 | 22 | $385.4K |
| Q4 2025 | 21 | $272.4K |
| Q3 2025 | 20 | $177.0K |
| Q2 2025 | 17 | $126.3K |
| Q1 2025 | 11 | $209.8K |
| Q4 2024 | 10 | $60.3K |
| Q3 2024 | 18 | $678.6K |
| Q2 2024 | 22 | $327.6K |
| Q1 2024 | 24 | $366.3K |
| Q4 2023 | 24 | $452.3K |
| Q3 2023 | 21 | $572.8K |
| Q2 2023 | 18 | $1.01M |
| Q1 2023 | 19 | $724.6K |
| Q4 2022 | 22 | $477.1K |
| Q3 2022 | 26 | $1.15M |
| Q2 2022 | 33 | $2.51M |
| Q1 2022 | 35 | $3.17M |
| Q4 2021 | 35 | $3.24M |
| Q3 2021 | 36 | $3.32M |
| Q2 2021 | 31 | $3.91M |
| Q1 2021 | 32 | $5.80M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Theriva Biologics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MSD Partners, L.P. | 598,411 | $141.4K | 0.01% | +598,411 | New |
| Vanguard Group Inc | 194,494 | $46.0K | 0.00% | −30,777−13.7% | Reduced |
| BlackRock Inc. | 189,181 | $44.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 141,168 | $33.4K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 103,710 | $24.5K | 0.00% | +35,200+51.4% | Added |
| Two Sigma Securities, LLC | 61,023 | $14.4K | 0.00% | +39,750+186.9% | Added |
| State Street Corp | 48,691 | $11.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,477 | $6.26K | 0.00% | −122−0.5% | Reduced |
| Advisor Group Holdings, Inc. | 11,047 | $2.61K | 0.00% | +11,000+23,404.3% | Added |
| Blair William & Co | 10,153 | $2.40K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 500 | $118 | 0.00% | +490+4,900.0% | Added |
| Iron Horse Wealth Management, LLC | 365 | $86 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 296 | $70 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 145 | $34 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 146 | $34 | 0.00% | +140+2,333.3% | Added |
| Planning Capital Management Corp | 110 | $26 | 0.00% | +110 | New |
| Wells Fargo & Company | 100 | $24 | 0.00% | −133−57.1% | Reduced |
| Old Point Trust & Financial Services N A | 100 | $24 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 15 | $4 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 14 | $3 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 9 | $0 | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −24,679−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −13,566−100.0% | Sold out |
| Lincoln National Corp | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −10,429−100.0% | Sold out |